Saturday, April 22, 2017 10:53:54 AM
Sorry, one of my links was bad: http://www.marketwired.com/press-release/sunshine-biopharmas-wholly-owned-canadian-subsidiary-completes-sops-required-health-otcqb-sbfm-1952414.htm
This is their lie about a drug license years ago...idk, ask them what happened?! Looked pretty convincing at the time....October 1, 2014......when asking Health Canada if they have ever received anything from Sunshine Biopharma, guess what their response was.........We have never received an application.
Take a look: they make all these claims....where is the actual data? Not in Canada...
https://www.canada.ca/en/health-canada/services/inspecting-monitoring-drug-health-products/drug-health-product-inspections.html
https://health-products.canada.ca/mdel-leim/dispatch-mdel-repartition-lepim.do
I can't find Sunshine, Advanomics, or the correct Atlas in health Canada's database. I reached out to the Atlas that Sunshine references on their PR, let's see if they respond ;)
This is a web of lies and deception to make money, not a real company.
This is their lie about a drug license years ago...idk, ask them what happened?! Looked pretty convincing at the time....October 1, 2014......when asking Health Canada if they have ever received anything from Sunshine Biopharma, guess what their response was.........We have never received an application.
Take a look: they make all these claims....where is the actual data? Not in Canada...
https://www.canada.ca/en/health-canada/services/inspecting-monitoring-drug-health-products/drug-health-product-inspections.html
https://health-products.canada.ca/mdel-leim/dispatch-mdel-repartition-lepim.do
I can't find Sunshine, Advanomics, or the correct Atlas in health Canada's database. I reached out to the Atlas that Sunshine references on their PR, let's see if they respond ;)
This is a web of lies and deception to make money, not a real company.
Recent SBFM News
- Sunshine Biopharma Announces Canadian Approval for Rivaroxaban, a Generic Form of Xarelto(R) • ACCESS Newswire • 06/01/2026 12:00:00 PM
- Sunshine Biopharma Announces Issuance of U.S. Patent 12,624,066 B2 Covering Novel Coronavirus Treatment Technology • ACCESS Newswire • 05/29/2026 12:00:00 PM
- Sunshine Biopharma Announces Reverse Stock Split to Maintain NASDAQ Listing • ACCESS Newswire • 05/28/2026 01:00:00 PM
- Sunshine Biopharma Receives Canadian Regulatory Approval for Generic Amoxicillin • ACCESS Newswire • 05/21/2026 11:00:00 AM
- Sunshine Biopharma Inc. Announces Closing of up to $18.0 Million Public Offering • ACCESS Newswire • 05/19/2026 04:05:00 PM
- Sunshine Biopharma Inc. Announces Pricing of $6.0 Million Public Offering • ACCESS Newswire • 05/18/2026 04:15:00 PM
- Sunshine Biopharma Reports Fiscal 2025 Revenue of $36.3 Million, a 4.1% Increase Over Prior Year • ACCESS Newswire • 04/06/2026 12:30:00 PM
- Sunshine Biopharma Gains FDA-Equivalent Clearance in Canada for Domperidone to Treat Cancer-related Nausea • ACCESS Newswire • 10/28/2025 11:45:00 AM
- Sunshine Biopharma Launches STD, Acne and Lyme Disease Therapy Doxycycline • ACCESS Newswire • 10/20/2025 11:45:00 AM
- Sunshine Biopharma Launches Cholesterol Fighting Medicine Pravastatin • ACCESS Newswire • 10/16/2025 11:45:00 AM
- Sunshine Biopharma Allocates $5 Million for Investment in Bitcoin as Strategic Reserve Asset to Enhance Treasury Resilience • ACCESS Newswire • 10/14/2025 11:00:00 AM
- Sunshine Biopharma and University of Arizona Develop a Potent New Series of Protease Inhibitors for Treatment of SARS Coronavirus Infections • ACCESS Newswire • 10/09/2025 12:00:00 PM
